The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36652904.
- Also identified by DOI 10.1016/j.xcrm.2022.100835 and PMC identifier 9873818.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fertility has become a priority in transgender health research. In this issue of Cell Reports Medicine, a study by de Nie et al.<sup>1</sup> of nine transgender women demonstrates sperm production after the cessation of gender-affirming hormone therapy (GAHT). Their results suggest the transient nature of gonadal suppression by GAHT.
Medical subject headings
- Transgender Persons
- Medicine